CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
iThrive WI Interventiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05518461
NCT05518461N/ACompleted
CompareCT.gov

iThrive WI - A Smartphone Intervention for Overdose and Risk and COVID-19 Among People Who Use Drugs

University of Wisconsin, Madison·interventional·Posted Aug 26, 2022·Updated Dec 5, 2024

In Brief

A clinical study evaluating iThrive WI Intervention for Substance Use Disorders and 2 related conditions. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study will examine if the use of a smartphone application called Thrive4Life Connect can help people who use drugs lower their risk of overdose and learn more about COVID-19 vaccines. 60 participants will be enrolled and can expect to be on study for up to 6 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubstance Use Disorders, Overdose, COVID-19
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 26, 2022
Enrollment StartDec 19, 2022
Primary CompletionDec 15, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 3.9 years ago

Interventions

iThrive WI Interventiondevice

Participants will receive COVID-19 and overdose-related educational and motivational content over the course of 12 weeks through the Thrive4Life Connect, a mobile health application. They will be invited to set goals for lowering overdose and COVID-19 risk.